We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ABSI icon
326
Absci
ABSI
$1.44B
$1.44B $8.48 6.94%
PSNL icon
327
Personalis
PSNL
$1.41B
$1.41B $13.52 2.42%
KMTS
328
Kestra Medical Technologies
KMTS
$1.41B
$1.41B $25.93 8.09%
XERS icon
329
Xeris Biopharma Holdings
XERS
$1.4B
$1.4B $8.19 0.74%
PNTG icon
330
Pennant Group
PNTG
$1.4B
$1.4B $38.61 3.91%
IART icon
331
Integra LifeSciences
IART
$1.39B
$1.39B $17.90 0.11%
TNDM icon
332
Tandem Diabetes Care
TNDM
$1.38B
$1.38B $20.20 0.45%
AZTA icon
333
Azenta
AZTA
$1.38B
$1.38B $30.13 0.84%
AORT icon
334
Artivion
AORT
$1.33B
$1.33B $26.90 2.07%
GLUE icon
335
Monte Rosa Therapeutics
GLUE
$1.3B
$1.3B $16.08 4.55%
AMN icon
336
AMN Healthcare
AMN
$1.29B
$1.29B $33.25 0.76%
ALVO icon
337
Alvotech
ALVO
$1.28B
$1.28B $3.84 1.32%
AVLN
338
Avalyn Pharma
AVLN
$1.26B
$1.26B $30.73 7.82%
AKTS
339
Aktis Oncology
AKTS
$1.26B
$1.26B $22.84 2.74%
NVAX icon
340
Novavax
NVAX
$1.26B
$1.26B $7.66 3.37%
ETON icon
341
Eton Pharmaceutcials
ETON
$1.24B
$1.24B $45.83 1.53%
IMTX icon
342
Immatics
IMTX
$1.23B
$1.23B $9.38 3.99%
ARDX icon
343
Ardelyx
ARDX
$1.23B
$1.23B $5.01 0.6%
LBRX
344
LB Pharmaceuticals
LBRX
$1.23B
$1.23B $45 5.04%
TDOC icon
345
Teladoc Health
TDOC
$1.21B
$1.21B $6.71 0.45%
INBX icon
346
Inhibrx
INBX
$1.21B
$1.21B $83.53 0.98%
CERT icon
347
Certara
CERT
$1.21B
$1.21B $7.80 4.65%
STAA icon
348
STAAR Surgical
STAA
$1.21B
$1.21B $24.12 0.9%
QDEL icon
349
QuidelOrtho
QDEL
$1.21B
$1.21B $17.58 0.73%
VOR icon
350
Vor Biopharma
VOR
$1.21B
$1.21B $22.25 3.92%
12 13
14
15 16

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.91T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $613B and AbbVie (ABBV) at $433B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.91T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.